Programme - BLADDR 2019 - Global Congress on Bladder Cancer

Scientific programme

 

Day 0 – Thursday 24 October 2019

15:00

 

Opening registration desk for BLADDR
17:00

 

Keynote lecture (for PROSCA & BLADDR participants)
17:00

 

Fabrication, falsehood & plagiarism: the unholy trinity of scientific misbehaviour 
Anthony Zietman

17:30

 

Q&A

]
17:30

 

Close PROSCA
17:35

 

Networking reception for PROSCA & BLADDR participants

Day 1 – Friday 25 October 2019

08:30

 

Opening exhibition & welcome coffee
09:00

 

Official opening: the road to Paris

Jacques Irani – Yohann Loriot

09:20

 

Management of NMIBC in 2019

Chair: Jacques Irani

09:20

 

New therapies for BCG unresponsive NMIBC: where do we stand?
Ashish Kamat

09:40
 

Case discussion on diagnosis and treatment
Moderator: Jacques Irani
Panel: Kilian M. Gust – Ashish Kamat – Jeroen van Moorselaar

10:20

 

Q&A

10:45

 

Coffee break & interactive poster viewing
11:15

 

Pearls and pitfalls in diagnosing and classifying bladder tumours

Chair: Annemarie Leliveld

11:15

 

Diagnostic imaging for haematuria and bladder cancer: a fresh perspective challenging the status quo
Nigel Cowan

11:35

 

Pathology and molecular data, where can we meet?
Eva Comperat

11:55

 

PD-L1 testing: when and how

12:15

 

Q&A

12:30

 

Lunch break & interactive poster viewing
13:25

 

Welcome afternoon – day 1
13:30

 

Advanced urothelial cancer

Chair: Andrea Necchi – Thomas Powles

13:30

 

New treatment options beyond immunotherapy
(including FGFR and antibody conjugates)

Yohann Loriot

13:50

 

A practical guide to biomarkers
Petros Grivas

14:10

 

Combination or sequencing, ready for primetime?
Ignacio Durán

14:30

 

Q&A

15:00

 

Coffee break & interactive poster viewing
15:30

 

Quality of care and quality of life as drivers of treatment decisions

Chair: Maria De Santis – Valérie Fonteyne

15:30

 

SIOG update: treating elderly patients with bladder cancer
Nicolas Mottet
15:45

 

Immunotherapy: the patient’s point of view
Thomas Powles

16:00

 

Panel discussion
Nicolas Mottet – Thomas Powles

16:15

 

Q&A

16:30

 

Debate: the optimal therapy for a patient with high-risk NMIBC: RC vs. intravesical therapy vs. TMT

Moderators: Ananya Choudhury – Nicolas Mottet

16:30

 

Case-based debate with voting rounds
Jacques Irani – Ashish Kamat – Anthony Zietman

]
17:15

 

Close day 1

Day 2 – Saturday 26 October 2019

08:00

 

Opening exhibition & welcome coffee
08:25

 

Welcome morning – day 2

Anthony Zietman

08:30

 

Bladder cancer: practical directions for day-to-day decisions

Chair: Jeroen van Moorselaar – Anthony Zietman

08:30

 

Surgery-related complications and how to prevent them
Kilian M. Gust

08:45

 

Optimal trimodality treatment: what does it look like?
Valérie Fonteyne

09:00

 

Germline mutations: which patients need genetic testing today?
Ignacio Durán

09:15

 

Q&A

09:45

 

Best poster session

Chair: Maria De Santis
Up to 3 case reports or clinical data presented by delegates and commented by expert panel: Petros Grivas – Peter Hoskin

09:45
 
Discussions
09:55
 
Case 2
10:05
 

Case 3

10:15
Award ceremony and Q&A
10:30

 

Coffee break & interactive poster viewing
11:00

 

Management of UTUC in 2019

Chair: Kilian M. Gust

11:00
Treatment of advanced UTUC
TBC
11:20
Management of bladder and upper urinary tract urothelial carcinoma with targeted Copy Number Variations Profiling
Eva Comperat
11:30
Q&A
11:40

 

Management of MIBC

Chair: Ananya Choudhury

11:40

 

Frozen section during radical cystectomy: is it still relevant?
Jacques Irani

11:55

 

Bladder preservation in MIBC: give me some oxygen
Peter Hoskin

12:10

 

Immunotherapy for MIBC: the future is now (neoadjuvant/adjuvant/maintenance therapy)
TBC

12:25

 

Case-based discussion
Ananya Choudhury

12:45

 

Q&A

]
13:00

 

Close & farewell BLADDR

Ananya Choudhury – Maria De Santis

13:05

 

Lunch (take away box)
Legend:
Lecture

 

Debate/ panel discussion

 

Q&A

 

For mobile:

 

Cité Internationale Universitaire de Paris

Mirrors of Medicine

Organised by
ISSECAM

Congress management by
e-HIMS

Endorsed by ESTRO